Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.
Ma X, Le Teuff G, Lacas B, Tsao MS, Graziano S, Pignon JP, Douillard JY, Le Chevalier T, Seymour L, Filipits M, Pirker R, Jänne PA, Shepherd FA, Brambilla E, Soria JC, Hainaut P; LACE-Bio Collaborative Group. Ma X, et al. Among authors: pirker r. J Thorac Oncol. 2016 Jun;11(6):850-61. doi: 10.1016/j.jtho.2016.02.002. Epub 2016 Feb 17. J Thorac Oncol. 2016. PMID: 26899019 Free article. Clinical Trial.
Multidrug resistance in leukemias and its reversal.
Malayeri R, Filipits M, Suchomel RW, Zöchbauer S, Lechner K, Pirker R. Malayeri R, et al. Among authors: pirker r. Leuk Lymphoma. 1996 Nov;23(5-6):451-8. doi: 10.3109/10428199609054853. Leuk Lymphoma. 1996. PMID: 9031075 Review.
MRP and MDR1 gene expression in primary breast carcinomas.
Filipits M, Suchomel RW, Dekan G, Haider K, Valdimarsson G, Depisch D, Pirker R. Filipits M, et al. Among authors: pirker r. Clin Cancer Res. 1996 Jul;2(7):1231-7. Clin Cancer Res. 1996. PMID: 9816292
The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.
Kandioler-Eckersberger D, Kappel S, Mittlböck M, Dekan G, Ludwig C, Janschek E, Pirker R, Wolner E, Eckersberger F. Kandioler-Eckersberger D, et al. Among authors: pirker r. J Thorac Cardiovasc Surg. 1999 Apr;117(4):744-50. doi: 10.1016/S0022-5223(99)70295-3. J Thorac Cardiovasc Surg. 1999. PMID: 10096970 Free article.
227 results